
Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 30-Aug-2022 titled Hikma launches RVALTRIS��� seasonal allergic rhinitis nasal spray in the US
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 30-Aug-2022 titled Hikma launches RVALTRIS��� seasonal allergic rhinitis nasal spray in the US
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals